Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain.

Chung SD, Wang CC, Kuo HC.

Neurourol Urodyn. 2014 Oct;33(8):1207-11. doi: 10.1002/nau.22477. Epub 2013 Aug 29.

PMID:
23996856
[PubMed - in process]
2.
3.

Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion.

Kim HJ, Lee JS, Cho WJ, Lee HS, Lee HN, You HW, Jung W, Lee KS.

Int J Urol. 2014 Apr;21 Suppl 1:69-73. doi: 10.1111/iju.12320.

PMID:
24807503
[PubMed - in process]
4.

Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.

Almodhen F, Capolicchio JP, Jednak R, El Sherbiny M.

J Urol. 2007 Oct;178(4 Pt 1):1479-82. Epub 2007 Aug 16.

PMID:
17706702
[PubMed - indexed for MEDLINE]
5.
6.

Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.

Utomo E, Groen J, Blok BF.

Cochrane Database Syst Rev. 2014 May 24;5:CD004927. doi: 10.1002/14651858.CD004927.pub4.

PMID:
24859260
[PubMed - in process]
7.

Outcomes of lower urinary and bowel function in meningomyelocele patients with augmentation enterocystoplasty.

Mitsui T, Tanaka H, Moriya K, Matsuda M, Nonomura K.

Spinal Cord. 2008 Jun;46(6):432-7. doi: 10.1038/sj.sc.3102164. Epub 2008 Mar 4.

PMID:
18317489
[PubMed - indexed for MEDLINE]
8.

Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.

Kuo HC.

Int J Clin Pract. 2013 May;67(5):427-34. doi: 10.1111/ijcp.12113.

PMID:
23574103
[PubMed - indexed for MEDLINE]
9.

Effects of combination treatment of intravesical resiniferatoxin instillation and hydrodistention in patients with refractory painful bladder syndrome/interstitial cystitis: a pilot study.

Ham BK, Kim JH, Oh MM, Lee JG, Bae JH.

Int Neurourol J. 2012 Mar;16(1):41-6. doi: 10.5213/inj.2012.16.1.41. Epub 2012 Mar 31.

PMID:
22500253
[PubMed]
Free PMC Article
10.

Bladder functional outcome after delayed vesicostomy closure and antireflux surgery in young infants with 'primary' vesico-ureteric reflux.

Podesta ML, Ruarte A, Herrera M, Medel R, Castera R.

BJU Int. 2001 Apr;87(6):473-9.

PMID:
11298037
[PubMed - indexed for MEDLINE]
11.

The destruction of the lower urinary tract by ketamine abuse: a new syndrome?

Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JM, Lau FL, Yiu MK, Man CW.

BJU Int. 2008 Dec;102(11):1616-22. doi: 10.1111/j.1464-410X.2008.07920.x. Epub 2008 Aug 1.

PMID:
18680495
[PubMed - indexed for MEDLINE]
12.

Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures.

Ng CF, Chiu PK, Li ML, Man CW, Hou SS, Chan ES, Chu PS.

Int Urol Nephrol. 2013 Oct;45(5):1245-51. doi: 10.1007/s11255-013-0501-4. Epub 2013 Jul 18.

PMID:
23864416
[PubMed - indexed for MEDLINE]
13.

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.

J Urol. 2006 Jul;176(1):177-85.

PMID:
16753396
[PubMed - indexed for MEDLINE]
14.

Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury.

Chen JL, Kuo HC.

J Formos Med Assoc. 2009 Jun;108(6):475-80. doi: 10.1016/S0929-6646(09)60095-4.

PMID:
19515628
[PubMed - indexed for MEDLINE]
15.

Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.

Nitti VW, Rosenberg S, Mitcheson DH, He W, Fakhoury A, Martin NE.

J Urol. 2013 Oct;190(4):1320-7. doi: 10.1016/j.juro.2013.05.062. Epub 2013 May 30.

PMID:
23727415
[PubMed - indexed for MEDLINE]
16.

Changing concepts concerning the management of vesicoureteral reflux.

Herndon CD, DeCambre M, McKenna PH.

J Urol. 2001 Oct;166(4):1439-43.

PMID:
11547107
[PubMed - indexed for MEDLINE]
17.

The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome.

Kuo YC, Kuo HC.

Int J Clin Pract. 2013 Sep;67(9):863-9. doi: 10.1111/ijcp.12116.

PMID:
23952465
[PubMed - indexed for MEDLINE]
18.

Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity.

Wang CC, Liao CH, Kuo HC.

Neurourol Urodyn. 2014 Oct;33(8):1235-9. doi: 10.1002/nau.22494. Epub 2013 Sep 23.

PMID:
24115083
[PubMed - in process]
19.

Does the type of bladder augmentation influence the resolution of pre-existing vesicoureteral reflux? Urodynamic studies.

Juhasz Z, Somogyi R, Vajda P, Oberritter Z, Fathi K, Pinter AB.

Neurourol Urodyn. 2008;27(5):412-6.

PMID:
17985371
[PubMed - indexed for MEDLINE]
20.

Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder.

Liao L, Zhang F, Chen G.

Int Urol Nephrol. 2014 Nov;46(11):2117-25. doi: 10.1007/s11255-014-0782-2. Epub 2014 Jul 23.

PMID:
25053014
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk